Related by context. All words. (Click for frequent words.) 76 bevacizumab 76 docetaxel 76 gemcitabine 75 erlotinib 73 rituximab 73 pemetrexed 73 sorafenib 73 trastuzumab 73 Taxotere ® 73 capecitabine 72 cisplatin 72 sunitinib 72 temozolomide 72 carboplatin 72 docetaxel chemotherapy 72 imatinib 71 dasatinib 71 Vectibix 71 Taxotere 71 bevacizumab Avastin 71 bendamustine 70 FOLFOX 70 fluorouracil 70 bortezomib 70 gefitinib 70 FOLFIRI 70 lapatinib 70 metastatic colorectal cancer 70 vinorelbine 69 azacitidine 69 decitabine 69 vandetanib 69 carboplatin paclitaxel 69 dacarbazine 68 temsirolimus 68 gemcitabine chemotherapy 68 paclitaxel 68 irinotecan 68 topotecan 68 leucovorin 68 5FU 68 Cetuximab 68 chemoradiotherapy 68 5-FU/LV 68 trabectedin 67 oxaliplatin 67 Fludara 67 adalimumab 67 5 fluorouracil 67 adjuvant chemotherapy 67 tocilizumab 67 panitumumab 67 chlorambucil 67 anastrozole 67 Hycamtin 67 Taxotere R 67 sorafenib Nexavar 67 XELOX 67 relapsed ovarian cancer 66 ixabepilone 66 FOLFOX4 66 mycophenolate mofetil 66 etanercept 66 cabazitaxel 66 zoledronic acid 66 chemotherapy regimens 66 cytarabine 66 Bevacizumab 66 adjuvant therapy 66 pertuzumab 66 metastatic renal cell carcinoma 66 pegylated liposomal doxorubicin 66 Xeloda 66 epirubicin 66 Herceptin trastuzumab 66 interferon alfa 66 Trastuzumab 66 fludarabine 66 azathioprine 66 ERBITUX 66 neoadjuvant chemotherapy 66 fulvestrant 66 HER2 positive metastatic breast 66 chemoradiation 66 Erlotinib 66 tamoxifen 65 pazopanib 65 advanced NSCLC 65 nab paclitaxel 65 mCRC patients 65 chronic lymphocytic leukemia CLL 65 KRAS status 65 Tarceva erlotinib 65 iniparib 65 Torisel 65 mitoxantrone 65 Doxil ® 65 letrozole 65 NSCLC 65 5 FU 65 docetaxel Taxotere 65 pomalidomide 65 standard chemotherapy regimen 65 interferon 65 Erbitux 65 nilotinib 65 Avastin 65 imatinib Gleevec 65 Cytoxan 65 Bortezomib 64 doxorubicin 64 adriamycin 64 gemcitabine Gemzar 64 methotrexate 64 Halaven 64 gemcitabine carboplatin 64 DMARDs 64 lenalidomide 64 chemotherapy regimen 64 etoposide 64 metastatic RCC 64 EGFR mutations 64 Irinotecan 64 anti TNF 64 Amrubicin 64 Lapatinib 64 eribulin 64 liposomal doxorubicin 64 ASA# 64 Gemcitabine 64 monotherapy 64 seliciclib 64 trastuzumab Herceptin 64 Rituximab 64 bevacizumab Avastin ® 64 pegylated interferon alfa 2b 64 zalutumumab 64 axitinib 63 goserelin 63 T DM1 63 paclitaxel carboplatin 63 Pemetrexed 63 HER2 positive 63 bleomycin 63 Gefitinib 63 anakinra 63 brain metastases 63 paclitaxel Taxol 63 metastatic breast cancer 63 daunorubicin 63 Avastin bevacizumab 63 TACE 63 Sutent 63 Imprime PGG 63 INTELENCE 63 DMARD 63 Tykerb 63 Tarceva 63 relapsed SCLC 63 peginterferon 63 neoadjuvant 63 Herceptin 63 Dasatinib 63 pegylated interferon 63 cisplatin chemotherapy 63 mCRC 63 TNF inhibitors 63 Docetaxel 63 Taxol paclitaxel 63 gefitinib Iressa 63 anthracyclines 63 aromatase inhibitor 63 mRCC 63 chemotherapies 63 EGFr 63 eribulin mesylate 63 ELOXATIN 63 olaparib 63 chemotherapy docetaxel 63 Rituxan 63 Velcade bortezomib 62 TYKERB 62 taxanes 62 enzastaurin 62 Cisplatin 62 OPAXIO 62 Revlimid 62 neoadjuvant therapy 62 aflibercept 62 mapatumumab 62 cetuximab Erbitux 62 imatinib therapy 62 Mylotarg 62 lamivudine 62 Revlimid lenalidomide 62 cytotoxic chemotherapy 62 CHOP chemotherapy 62 Nexavar 62 interferon alpha 62 Carboplatin 62 taxane therapy 62 infliximab 62 AVASTIN 62 chemotherapeutic drug 62 chemotherapeutic agents 62 Capecitabine 62 taxane 62 Femara 62 platinum refractory 62 EGFR inhibitors 62 adjuvant 62 CoFactor 62 HER2 positive breast cancer 62 Targretin 62 TORISEL 62 APTIVUS r 62 raltegravir 62 Imatinib 62 Sorafenib 62 hormonal therapy 62 bicalutamide 62 neoadjuvant treatment 62 cyclophosphamide 62 VIDAZA 62 biologic therapy 62 low dose cytarabine 62 sorafenib Nexavar ® 62 pioglitazone 62 rituximab Rituxan 62 alkylating agent 62 GnRH agonists 62 low dose dexamethasone 62 oblimersen 62 infusional 5-FU/LV 62 Navelbine 62 standard chemotherapy regimens 62 intravenous bisphosphonates 62 tyrosine kinase inhibitors 62 Erbitux cetuximab 62 tyrosine kinase inhibitor 62 abiraterone 62 Vidaza 62 Oxaliplatin 62 docetaxel Taxotere R 62 Sunitinib 62 plus dexamethasone 62 squamous histology 62 sunitinib malate 62 recurrent ovarian cancer 62 surrogate endpoint 62 adecatumumab 61 Zolinza 61 preoperative chemotherapy 61 exemestane 61 VELCADE 61 estramustine 61 itraconazole 61 glatiramer acetate 61 afatinib 61 Lenalidomide 61 LY# [003] 61 amrubicin 61 idraparinux 61 PegIntron 61 fondaparinux 61 tipranavir 61 bortezomib Velcade 61 antitumor activity 61 gastrointestinal stromal tumor GIST 61 PXD# 61 Gemzar ® 61 unresectable 61 cetuximab Erbitux ® 61 ritonavir boosted 61 posaconazole 61 DOXIL 61 heavily pretreated patients 61 YONDELIS 61 insulin glargine 61 erlotinib Tarceva ® 61 adalimumab Humira 61 dexamethasone Decadron 61 milatuzumab 61 imetelstat 61 heavily pretreated 61 citalopram 61 Taxotere docetaxel 61 free survival PFS 61 BAY #-# 61 peginterferon alfa 61 ribavirin RBV 61 non squamous NSCLC 61 CANCIDAS 61 Taxol 61 Neoadjuvant 61 chemotherapeutic agent 61 FOLFOX regimen 61 Doxil 61 Peg IFN 61 octreotide LAR 61 IRESSA 61 CA4P 61 idarubicin 61 clodronate 61 MabThera 61 fluoropyrimidine 61 NRTIs 61 febuxostat 61 IMGN# 61 KRAS mutations 61 vorinostat 61 K ras mutations 61 tanespimycin 61 valopicitabine 61 Roche Pegasys 61 clopidogrel 61 erlotinib Tarceva 61 EGFR mutation 61 Fludarabine 61 BEACOPP 61 indolent NHL 60 SCCHN 60 EGFR 60 glufosfamide 60 plus gemcitabine 60 TNF inhibitor 60 relapsed CLL 60 ipilimumab 60 imatinib resistant 60 irinotecan chemotherapy 60 irbesartan 60 BRAF inhibitor 60 YERVOY 60 cilengitide 60 Ixempra 60 chemotherapy cisplatin 60 sulfasalazine 60 recurrent glioblastoma multiforme 60 plus prednisone 60 malignant pleural mesothelioma 60 nitazoxanide 60 dose cytarabine 60 cediranib 60 peginterferon alfa 2a 60 antitumor effect 60 gastrointestinal stromal tumors 60 pegylated interferon alpha 60 talabostat 60 paclitaxel chemotherapy 60 HuMax CD4 60 pancreatic adenocarcinoma 60 PREZISTA r 60 eplerenone 60 anti androgen 60 leflunomide 60 lapatinib Tykerb 60 Pegintron 60 stage IIIB 60 locoregional 60 Pegylated Interferon 60 Taxol ® 60 MGd 60 neratinib 60 Peginterferon 60 Pegasys ® 60 Ribavirin 60 Gleevec 60 Alimta 60 Xelox 60 GnRH agonist 60 FluCAM 60 immunosuppressant 60 Sanofi Aventis Taxotere 60 teriparatide 60 Gleevec imatinib 60 DAPT 60 pegfilgrastim 60 Folfox 60 peginterferon alfa 2b 60 abatacept 60 Ceflatonin 60 HGS ETR1 60 mTOR inhibitors 60 ceftriaxone 60 dasatinib Sprycel ® 60 Paraplatin ® 60 trastuzumab Herceptin R 60 interferon alfa 2a 60 conventional DMARDs 60 allopurinol 60 Xcytrin 60 Exemestane 60 Camptosar ® 60 plus ribavirin 60 memantine 60 resectable 60 epoetin alfa 60 lopinavir r 60 uric acid lowering 60 RG# [001] 60 ZOLINZA 60 capecitabine Xeloda 60 metastatic colon cancer 60 MabCampath 60 Neulasta ® 60 endocrine therapy 60 Tarceva TM 60 HuMax CD# 60 hormone receptor positive 60 docetaxel Taxotere ® 60 interferon IFN 59 ramipril 59 panitumumab Vectibix 59 peg IFN 59 dacarbazine chemotherapy 59 Cremophor 59 liver metastases 59 Votrient 59 romiplostim 59 vicriviroc 59 Aromasin 59 Epivir 59 Pfizer Sutent 59 galiximab 59 LHRH agonists 59 adjuvant radiation 59 FTY# 59 darunavir 59 mg kg dose 59 EGFR mutation positive 59 celecoxib 59 figitumumab 59 fallopian tube carcinoma 59 metastatic CRC 59 dasatinib Sprycel 59 nelfinavir 59 metformin 59 Sandostatin LAR 59 angiogenesis inhibitor 59 entecavir 59 KRAS mutant tumors 59 levodopa 59 trastuzumab Herceptin ® 59 denileukin diftitox 59 EGFR tyrosine kinase inhibitors 59 protease inhibitor PI 59 pegylated interferon alfa 59 T#I [002] 59 follicular NHL 59 Iressa 59 Yervoy 59 tamsulosin 59 Xanafide 59 relapsed refractory 59 placebo dexamethasone 59 PegIFN RBV 59 tumor shrinkage 59 cyclophosphamide Cytoxan 59 overlapping toxicities 59 Afinitor 59 recurrent NSCLC 59 Traficet EN 59 postoperative chemotherapy 59 FOLFOX6 59 Gemzar 59 COPAXONE R 59 luteinizing hormone releasing 59 Aptivus ® 59 Gliadel Wafer 59 regorafenib 59 chemotherapeutic regimens 59 Rituxan rituximab 59 IFN alfa 59 KRAS wild 59 pegylated interferon alfa 2a 59 recurrent GBM 59 teriflunomide 59 TTF Therapy 59 MAGE A3 ASCI 59 fluvastatin 59 receptor tyrosine kinase inhibitor 59 Alemtuzumab 59 Velcade 59 metastatic GIST 59 TKIs 59 mirtazapine 59 ofatumumab 59 interferon alfa 2b 59 efalizumab 59 ISENTRESS 59 perifosine 59 paclitaxel cisplatin 59 metastatic colorectal 59 Copegus ribavirin 59 leukemia CLL 59 active comparator 59 Jevtana 59 epoetin beta 59 cetuximab Erbitux R 59 Platinol ® cisplatin 59 anthracycline 59 CsA 59 DFMO 59 HER2 negative 59 Atacand 59 chemotherapy gemcitabine 59 tenofovir emtricitabine 59 viral kinetics 59 interferon beta 1a 59 fluconazole 59 tumor recurrence 59 Everolimus 59 clopidogrel Plavix 59 abacavir Ziagen 59 picoplatin 59 sevelamer 59 ARIMIDEX 59 Campath 59 G CSF 59 abciximab 59 TAXOTERE R 59 infliximab Remicade 59 follicular lymphoma 59 ZD# [001] 59 Platinol 59 tiotropium 59 candesartan 59 Rebif ® 59 relapsing multiple sclerosis 59 EGFR TKI 59 alpha interferon 59 d4T 59 KRAS mutations occur 59 pCR 59 Gleevec resistant 59 capecitabine Xeloda R 59 HuMax EGFr 58 everolimus 58 ACZ# 58 melphalan prednisone 58 dutasteride 58 superficial bladder cancer 58 FASLODEX 58 GM CSF 58 calcineurin inhibitors 58 TREANDA 58 voriconazole 58 IFN alpha 58 tamoxifen therapy 58 Adriamycin 58 Paclitaxel 58 interferon beta 58 resistant ovarian cancer 58 Navelbine ® 58 Genasense 58 VELCADE melphalan 58 Nexavar ® 58 Metastatic Colorectal Cancer 58 tolvaptan 58 oxaliplatin Eloxatin 58 docetaxel prednisone 58 5 fluorouracil leucovorin 58 elotuzumab 58 androgen independent 58 immunotherapy 58 entinostat 58 Femara letrozole 58 selegiline 58 sipuleucel T 58 Allovectin 7 ® 58 interferon ribavirin 58 LEXIVA r 58 atazanavir 58 metastatic hormone refractory 58 dose dexamethasone 58 palliative radiotherapy 58 Alkeran 58 Actemra 58 Sprycel 58 oral Xeloda 58 sorafenib tablets 58 FOLFIRINOX 58 paclitaxel Taxol R 58 adefovir 58 splenectomized patients 58 PLX# 58 rFVIIa 58 daclizumab 58 thalidomide Thalomid 58 paricalcitol 58 ACE inhibitor 58 PROMACTA 58 metastatic malignant 58 chemotherapy FOLFOX 58 chronic myeloid leukemia CML 58 taxol 58 ribavirin 58 chemotherapy 58 tesmilifene 58 Vandetanib 58 melphalan 58 SUTENT 58 KRAS mutation 58 Adalimumab 58 taxane chemotherapy 58 pregabalin 58 Xeloda capecitabine 58 Taxotere chemotherapy 58 baminercept 58 azacytidine 58 cardiac toxicity 58 Arixtra 58 oral clodronate 58 Rebetol 58 FOLPI 58 anticancer agent 58 PROSTVAC ® 58 abiraterone acetate 58 GRN#L 58 interferon therapy 58 peginterferon alfa 2a Pegasys 58 Reolysin 58 4mg/kg 58 chemotherapeutic regimen 58 relapsed MM 58 cisplatin vinorelbine 58 omalizumab 58 ABVD 58 natalizumab 58 imatinib Gleevec ® 58 Treanda 58 TEMODAL 58 androgen deprivation 58 valsartan 58 chemoradiation therapy 58 hormone refractory prostate cancer 58 Hycamtin ® 58 XGEVA 58 mg/m2 dose 58 fluorouracil leucovorin 58 dexamethasone 58 CLL SLL 58 fingolimod 58 randomized Phase III 58 TNF antagonists 58 prednisone prednisolone 58 mitoxantrone chemotherapy 58 XYOTAX 58 sunitinib Sutent 58 corticosteroids 58 cilostazol 58 Pertuzumab 58 Adjuvant chemotherapy 58 Cyclophosphamide 58 antiplatelet therapy 58 Telcyta 58 histone deacetylase HDAC inhibitor 58 gadobutrol 58 tiotropium bromide 58 ACTEMRA TM 58 medullary thyroid cancer 58 APTIVUS 58 trabedersen 58 tigecycline 58 Dacogen injection 58 olmesartan 58 PREZISTA rtv 58 SCIg 58 epoetin 58 BCIRG 58 TNFerade 58 Aflibercept 58 #mg dose [001] 58 mutated KRAS 58 eltrombopag 58 refractory AML 58 EndoTAGTM 1 58 BEXXAR 58 rHuPH# 58 TELCYTA 58 tipifarnib 58 adjuvant radiotherapy 58 TroVax 58 losartan 58 alemtuzumab 58 glucocorticoids 58 TNF antagonist 58 Azacitidine 58 relapsed multiple myeloma 58 FOLFOX chemotherapy 58 gp# vaccine 58 stavudine d4T 58 comparator arm 58 complete remissions 58 QTc prolongation 58 virologic 58 aromatase inhibitors 58 ticagrelor 58 bosentan 58 GISTs 58 custirsen 58 Bevacizumab Avastin 58 nonsmall cell lung cancer 57 imiquimod 57 HRPC 57 xenograft models 57 Camptosar 57 distant metastasis 57 EFAPROXYN 57 FOLFIRI alone 57 median PFS 57 unresectable stage 57 Tavocept 57 belinostat 57 Amplimexon 57 calcineurin inhibitor 57 Bezielle 57 neurologic progression 57 Leukine 57 pegylated interferons 57 Amigal 57 ximelagatran 57 advanced unresectable 57 TroVax ® 57 octreotide 57 low dose ritonavir 57 ibandronate 57 hypercalcemia 57 Telintra 57 nucleoside analogue 57 cyclophosphamide methotrexate 57 dabigatran etexilate 57 peginterferon alpha 2a 57 FLT3 57 multicentre randomized 57 DMARDS 57 metastatic melanoma 57 protease inhibitor 57 colorectal liver metastases 57 beta interferon 57 bosutinib 57 lacosamide 57 NRTI 57 evaluating tivozanib 57 adjuvant tamoxifen 57 Tamoxifen 57 levosimendan 57 cidofovir 57 metastatic disease 57 levofloxacin 57 BMS # 57 imipenem 57 imatinib mesylate Gleevec 57 anti EGFR antibody 57 linezolid 57 prostate cancer mCRPC 57 bivalirudin 57 carvedilol 57 MetMAb 57 N acetylcysteine 57 imatinib resistance 57 GP IIb IIIa inhibitors 57 mcg dose 57 chemo radiotherapy 57 sorafenib Nexavar R 57 gemcitabine cisplatin 57 ocrelizumab 57 Eribulin 57 alefacept 57 IMA# 57 febrile neutropenia 57 ustekinumab 57 interferon gamma 1b 57 paclitaxel Taxol ® 57 endometrial hyperplasia 57 thymalfasin 57 isoproterenol 57 strontium ranelate 57 BRIM2 57 virologic response 57 letrozole Femara 57 refractory CLL 57 REMICADE ® 57 CIMZIA TM 57 relapsed myeloma 57 metastatic castration resistant 57 solid tumors 57 PEGINTRON 57 REVLIMID 57 abacavir lamivudine 57 mutated KRAS gene 57 5 Fluorouracil 57 visilizumab 57 CAELYX 57 mcg kg 57 Trabectedin 57 refractory multiple myeloma 57 statins 57 EBRT 57 metastatic pancreatic cancer 57 RoACTEMRA 57 fallopian tube cancers 57 oral antidiabetic 57 depsipeptide 57 Combination therapy 57 Nexavar sorafenib 57 anti leukemic 57 HSCT 57 pancreatic neuroendocrine tumors 57 immunomodulator 57 SLIT 57 complete cytogenetic response 57 Elitek 57 evaluable patients 57 HBeAg positive patients 57 clozapine 57 calcitriol 57 gastrointestinal stromal tumors GIST 57 doxorubicin cyclophosphamide 57 hormone LHRH agonist 57 meropenem 57 Mitoxantrone 57 differentiated thyroid 57 AZD# 57 Teriflunomide 57 interferons 57 lenalidomide dexamethasone 57 LPV r 57 Proxinium TM 57 cART 57 virologic failure 57 nonmetastatic 57 8mg/kg 57 prostate cancer CRPC 57 hematologic toxicity 57 somatostatin analogues 57 antiepileptic drug 57 IGFBP 3 57 ONTAK 57 ABRAXANE 57 HER2 + 57 simvastatin 57 TMC# [001] 57 ATACAND 57 invasive candidiasis 57 AZILECT 57 cancer mCRC 57 metastatic HRPC 57 leukemia AML 57 Abraxane 57 intratumoral injection 57 taxane refractory 57 INCB# [001] 57 stavudine 57 BARACLUDE ® 57 darunavir ritonavir 57 non squamous 57 sertraline 57 tacrolimus ointment 57 resected pancreatic cancer 57 anticancer therapy 57 liver metastasis 57 brentuximab vedotin 57 ORENCIA ® 57 Xeloda ® 57 microtubule inhibitor 57 complete cytogenetic 57 tenofovir Viread 57 Tasigna nilotinib 57 proteasome inhibitors 57 immunomodulatory therapy 57 hydroxyurea 57 basiliximab 57 dexpramipexole 57 INCB# [003] 57 alteplase 57 IV NSCLC 57 cell lung cancer 57 palifosfamide 57 Fludara ® 57 GVAX 57 degarelix 57 alpha 2a 57 Tocilizumab 57 tarenflurbil 57 telmisartan 57 TRISENOX 57 metastatic gastric 56 fosamprenavir 56 Noxafil 56 IMC A# 56 adjuvant trastuzumab 56 tyrosine kinase inhibitors TKIs 56 PD LID 56 thromboembolic events 56 Platinol ® 56 ZYVOX 56 castration resistant prostate cancer 56 HER2/neu 56 nucleoside analogs 56 IFN beta 56 cinacalcet 56 AZILECT R 56 chemotherapeutic drugs 56 satraplatin 56 hydroxychloroquine 56 vemurafenib 56 Elotuzumab 56 pan HDAC inhibitor 56 ADVEXIN 56 VFEND 56 zidovudine lamivudine 56 trastuzumab DM1 56 disease modifying 56 clusterin 56 Faslodex 56 bisphosphonates 56 sargramostim 56 lumiliximab 56 aflibercept VEGF Trap 56 ganetespib 56 MyVax R 56 mTOR inhibitor 56 CellCept 56 ALIMTA 56 alkylating agents 56 Degarelix 56 NOXAFIL 56 recurrent metastatic 56 eculizumab 56 romidepsin 56 sustained virologic response 56 EGFR TKIs 56 piperacillin tazobactam 56 LEXIVA 56 PKC# 56 Decitabine 56 doxorubicin Adriamycin 56 Interferon alfa 56 Onrigin 56 nilotinib Tasigna ® 56 Campath alemtuzumab 56 metastatic malignant melanoma 56 NeoRecormon 56 gemcitabine Gemzar ® 56 OncoVEX GM CSF 56 Tasigna 56 ZACTIMA 56 anti VEGF 56 anti TNFs 56 refractory CTCL 56 cytotoxic 56 histologies 56 lixisenatide 56 temozolomide TMZ 56 IFN α 56 Certolizumab pegol 56 canakinumab 56 lymph node metastases 56 Nilotinib 56 metastatic lung cancer 56 tumor progression 56 anticancer therapies 56 boosted protease inhibitor 56 Anastrozole 56 aspirin clopidogrel 56 metastatic kidney 56 corticosteroid therapy 56 VAPRISOL 56 trans retinoic acid 56 methotrexate therapy 56 5 FU leucovorin 56 Advexin 56 FOLOTYN 56 perampanel 56 ezetimibe 56 DLBCL 56 stage IIIB IV 56 systemic ALCL 56 Gleevec imatinib mesylate 56 angiotensin converting enzyme inhibitors 56 mepolizumab 56 glucose lowering 56 relapsing remitting multiple sclerosis 56 enfuvirtide 56 disease modifying antirheumatic 56 immunosuppressive therapies 56 Eli Lilly Gemzar 56 atrasentan 56 Vidaza azacitidine 56 follicular lymphoma FL 56 CYC# 56 methotrexate MTX 56 Caelyx 56 Metastatic 56 inhaled corticosteroids 56 timolol 56 dose escalation 56 DMARD therapy